Rating History for Krystal Biotech (KRYS) by RBC Capital

More Stocks Rated by RBC Capital | Latest Ratings for KRYS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/14/2026 N/A New Coverage Outperform
(N/A)		 400.00
(N/A)		 328.34
(363.84)		 10.81% Details